When should you not use abciximab?
When should you not use abciximab?
Contraindications
- Hypersensitivity to abciximab or component of the formulation.
- Recent (within six weeks) clinically significant gastrointestinal (GI) or genitourinary (GU) bleeding or active internal hemorrhage.
- Within two years of cerebrovascular accident or with substantial neurological deficit.
Does ReoPro inhibit platelet function?
ReoPro® inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor and other adhesive molecules to GPIIb/IIIa receptor sites on activated platelets.
What is the mechanism of action of abciximab?
Abciximab inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor, and other adhesive molecules to GPIIb/IIIa receptor sites on activated platelets. A single intravenous bolus dose from 0.15 mg/kg to 0.30 mg/kg produced rapid dose-dependent inhibition of platelet function.
Why was ReoPro discontinued?
Supplies of abciximab (ReoPro; Janssen Pharmaceuticals) are running low or have dried up altogether, following a manufacturing snafu affecting stocks of the glycoprotein IIb/IIIa Inhibitor around the globe.
Can abciximab cause thrombocytopenia?
Profound abciximab induced thrombocytopenia has an incidence of 8.5%. It occurs rapidly after drug infusion (within 2–4 h); upon discontinuation of abciximab, platelet values return to normal in 2–5 days, but may be prolonged past 10 days.
When do you use abciximab?
USES: Abciximab is a type of “blood thinner” used to prevent blood clots during certain procedures used to open up the blood vessels in the heart (e.g., balloon angioplasty, coronary stent placement, percutaneous coronary intervention-PCI). It is usually used with heparin and aspirin.
What is reopro used for?
Overview. Abciximab is used to lessen the chance of heart attack in people who need percutaneous coronary intervention (PCI), a procedure to open blocked arteries of the heart. A heart attack may occur when a blood vessel in the heart is blocked by a blood clot.
Is abciximab an anticoagulant?
It is a glycoprotein IIb/IIIa inhibitor. While abciximab has a short plasma half-life, due to its strong affinity for its receptor on the platelets, it may occupy some receptors for weeks….Abciximab.
| Monoclonal antibody | |
|---|---|
| Source | Chimeric (mouse/human) |
| Target | CD41 7E3 |
| Clinical data | |
| Trade names | Reopro |
Is reopro still available?
Janssen will no longer have Reopro in the US. The last lot expires September 2019.
How does abciximab cause Pseudothrombocytopenia?
Once HIT is excluded, it is also important to exclude pseudothrombocytopenia, which is specific to abciximab. Pseudothrombocytopenia is caused by platelet clumping, causing a falsely decreased platelet level.
What should I monitor with abciximab?
Monitor Closely (1)ibrutinib will increase the level or effect of abciximab by anticoagulation. Use Caution/Monitor. Ibrutinib may increase the risk of hemorrhage in patients receiving antiplatelet or anticoagulant therapies and monitor for signs of bleeding. Monitor Closely (1)icosapent, abciximab.
What class of drug is ReoPro?
Abciximab, a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing …
Are there any side effects to taking ReoPro?
In the EPIC trial, in which a non-weight-adjusted, standard heparin dose regimen was used, the most common complication during ReoPro ® (abciximab) therapy was bleeding during the first 36 hours. The incidences of major bleeding, minor bleeding and transfusion of blood products were approximately doubled.
What’s the correct dosage of Reopro for adults?
Proper Use of ReoPro. Adults – Initial dose: 250 micrograms (mcg) per kilogram (kg)of body weight injected. Maintenance dose: 10 mcg per minute by IV for 18 to 24 hours, ending 1 hour after the procedure.
What are the physicochemical properties of ReoPro?
Physicochemical properties: ReoPro ® is a clear, colourless, sterile, non-pyrogenic solution for intravenous (IV) use. ReoPro ® (abciximab) is a chimeric Fab fragment that binds to platelet glycoprotein IIb/IIIa.
How is ReoPro used to treat blood clots?
ReoPro reduces the chance that a harmful clot will form by preventing certain cells in the blood from clumping together. ReoPro is used with aspirin and heparin, which are other medicines used to keep your blood from clotting.
